Get started
23andMe Holding Co.23andMe Holding Co.23andMe Holding Co.

23andMe Holding Co.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

ME chart


Full chart

ME upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪14.23 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−15.7226 USD
Net income (FY)
‪−666.70 M‬ USD
Revenue (FY)
‪219.64 M‬ USD
Shares float
‪15.04 M‬
Beta (1Y)
1.34

Employees


Employees (FY)
582
Change (1Y)
−234 −28.68%
Revenue / Employee (1Y)
‪377.38 K‬ USD
Net income / Employee (1Y)
‪−1.15 M‬ USD

About 23andMe Holding Co.


Sector
Health Technology
Industry
Biotechnology
CEO
Joseph Selsavage
Website
23andme.com
Headquarters
San Francisco
Founded
2006
FIGI
BBG00XV5CYH5
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcicki in 2006 and is headquartered in San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ME news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ME.

Frequently Asked Questions


The current price of ME is 0.6390 USD — it has increased by 45.15% in the past 24 hours. Watch 23andMe Holding Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 23andMe Holding Co. stocks are traded under the ticker ME.
ME stock has fallen by −57.22% compared to the previous week, the month change is a −66.52% fall, over the last year 23andMe Holding Co. has showed a −93.88% decrease.
ME reached its all-time high on Feb 4, 2021 with the price of 363.2000 USD, and its all-time low was 1.3400 USD and was reached on Mar 4, 2025. View more price dynamics on ME chart.
See other stocks reaching their highest and lowest prices.
ME stock is 76.82% volatile and has beta coefficient of 1.34. Track 23andMe Holding Co. stock price on the chart and check out the list of the most volatile stocks — is 23andMe Holding Co. there?
Today 23andMe Holding Co. has the market capitalization of ‪20.66 M‬, it has increased by 28.21% over the last week.
Yes, you can track 23andMe Holding Co. financials in yearly and quarterly reports right on TradingView.
23andMe Holding Co. is going to release the next earnings report on May 22, 2025. Keep track of upcoming events with our Earnings Calendar.
ME earnings for the last quarter are −1.02 USD per share, whereas the estimation was −3.19 USD resulting in a 67.99% surprise. The estimated earnings for the next quarter are −2.43 USD per share. See more details about 23andMe Holding Co. earnings.
23andMe Holding Co. revenue for the last quarter amounts to ‪60.30 M‬ USD, despite the estimated figure of ‪41.10 M‬ USD. In the next quarter, revenue is expected to reach ‪48.76 M‬ USD.
ME net income for the last quarter is ‪−53.03 M‬ USD, while the quarter before that showed ‪−59.10 M‬ USD of net income which accounts for 10.27% change. Track more 23andMe Holding Co. financial stats to get the full picture.
No, ME doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 28, 2025, the company has 582 employees. See our rating of the largest employees — is 23andMe Holding Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 23andMe Holding Co. EBITDA is ‪−190.03 M‬ USD, and current EBITDA margin is −131.81%. See more stats in 23andMe Holding Co. financial statements.
Like other stocks, ME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 23andMe Holding Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 23andMe Holding Co. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 23andMe Holding Co. stock shows the sell signal. See more of 23andMe Holding Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.